Nörolojik Hastalık Genetik Panelleri
Alzheimer cardiovascular SNPs (Tek nükleotid polimorfizmleri) panel (Test yöntemi: Sanger sequencing, Test sonuçlanması: 20 gün, Numune türü: EDTA tüp)
ACT, APOE, IL-1B, IL-10, VEGF, HMGCR
Alzheimer Disease (expanded panel) panel (Test yöntemi: NGS, Test sonuçlanması: 20 gün, Numune türü: EDTA tüp)
APOE, APP, PRNP, PSEN1, PSEN2, SORL1, TREM2
Alzheimer Disease Early-Onset Autosomal dominant (PESEN1, PSEN2) (Test yöntemi: NGS, Test sonuçlanması: 20 gün, Numune türü: EDTA tüp)
PSEN2, PSEN1
Epilepsy (Comprehensive NGS panel) (Test yöntemi: NGS, Test sonuçlanması: 30 gün, Numune türü: EDTA tüp, bukkal swap)
ACY1, ADSL, ALDH7A1, AMT, ARHGEF9, ARX, ASAH1, CACNA1H, CACNB4, CDKL5, CHRNA2, CHRNA4, CHRNB2, CLCN2, CNTNAP2, CPA6, CPT2, CSTB, DRD2, EFHC1, EPM2A, FOLR1, FOXG1, GABRA1, GABRB3, GABRD, GABRG2, GAMT, GCSH, GLDC, GOSR2, GRIN2A, GRIN2B, JRK, KCNJ10, KCNMA1, KCNQ2, KCNQ3, KCTD7, LGI1, MAPK10, MBD5, MECP2, MEF2C, MFSD8, MTHFR, NEDD4L, NEU1, NHLRC1, NRXN1, PCDH19, PIGA, PIGO, PIGV, PLCB1, PNKP, PNPO, POLG, PPT1, PRICKLE1, PRICKLE2, PRRT2, RBFOX1, RNASEH2A, RNASEH2B, RNASEH2C, ROGDI, SAMHD1, SCARB2, SCN1A, SCN1B, SCN2A, SCN3A, SCN8A, SCN9A, SGCE, SLC19A3, SLC25A12, SLC25A22, SLC2A1, SLC6A8, SLC9A6, SPTAN1, SRPX2, ST3GAL3, ST3GAL5, STXBP1, SYN1, SYNGAP1, TBC1D24, TBCE, TCF4, TPP1, TREX1, TSC1, TSC2, UBE3A, WWOX, ZEB2
Epilepsy, febrile seizures, absences (expanded panel) (Test yöntemi: NGS, Test sonuçlanması: 30 gün, Numune türü: EDTA tüp)
ALDH7A1, CACNA1A, CACNA1H, CACNB4, CASR, CHRNA2, CHRNA4, CHRNB2, CLCN2, CSTB, EFHC1, ELP, EPM2A, GABRA1, GABRB3, GABRD, GABRG2, GPR98, GRIN2A, GRIN2B, KCNMA1, KCNQ2, KCNQ3, KCTD7, MBD5, NHLRC1, PCDH19, PRICKLE1, PRICKLE2, SCARB2, SCN1A, SCN1B, SCN2A, SCN9A, SLC2A1, TBC1D24
Epileptic Encephalopathies (panel) (Test yöntemi: NGS, Test sonuçlanması: 30 gün, Numune türü: EDTA tüp)
ACY1, ADSL, ALDH7A1, AMT, ARHGEF9, ARX, CDKL5, CNTNAP2, CPT2, FOLR1, FOXG1, GABRG2, GAMT, GCSH, GLDC, GRIN2A, GRIN2B, KCNJ10, KCNQ2, MAPK10, MECP2, MTHFR, NRXN1, PCDH19, PLCB1, PNKP, PNPO, PRRT2, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, SCN1A, SCN1B, SCN2A, SCN8A, SCN9A, SLC19A3, SLC25A22, SLC2A1, SLC9A6, SPTAN1, STXBP1, TBCE, TCF4, TREX1, UBE3A, ZEB2
Parkinsons Disease (Extended panel) (Test yöntemi: NGS, Test sonuçlanması: 30 gün, Numune türü: EDTA tüp)
ATP13A2, ATP1A3, ATP6AP2, DCTN1, DNAJC6, FBXO7, FTL, FUS, GBA, GCH1, GIGYF2, HTRA2, LRRK2, MAPT, PARK2, PARK7, PINK1, PLA2G6, PRKRA, SLC30A10, SLC6A3, SNCA, SNCB, SPR, TAF1, TH, UCHL1, VPS35
Parkinsons Disease (Pannello) (Test yöntemi: NGS, Test sonuçlanması: 20 gün, Numune türü: EDTA tüp)
EIF4G1, GBA, GIGYF2, HTRA2, LRRK2, MAPT, PARK2, PARK7, PINK1, SNCA, UCHL1, VPS35